Articoli anno 2000


Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
Llovet JM, Sala M, Castells L, Suarez Y, Vilana R, Bianchi L, Ayuso C, Vargas V, Rodes J, Bruix J Liver Unit, BCLC (Barcelona-Clinic Liver Cancer) Group, IDIBAPS (Institut d'Invertigacions Biomediques August Pi i Sunyer) Hospital Clinic Barcelona, Barcelona, Spain. Hepatology 2000 Jan;31(1):54-8

Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma
Nicoli N, Casaril A, Marchiori L, Mangiante G, Marini G, Colombari R, Portuese A, Hasheminia AR Department of Surgical and Gastroenterological Sciences, University of Verona. Chir Ital 2000 Jan-Feb;52(1):29-40

What patients can survive disease free after complete resection for hepatocellular carcinoma?: A multivariate analysis
Takata M, Yamanaka N, Tanaka T, Yamanaka J, Maeda S, Okamoto E, Yasojima H, Uematsu K, Watanabe H, Uragari Y First Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan. Jpn J Clin Oncol 2000 Feb;30(2):75-81

Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma
Koda M, Murawaki Y, Mitsuda A, Ohyama K, Horie Y, Suou T, Kawasaki H, Ikawa S Department of Clinical Laboratory Medicine, Tottori University, Tottori, Japan. Cancer 2000 Feb 1;88(3):529-37

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B
The European Concerted Action on Viral Hepatitis (Eurohep). Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW Servizio Autonomo Clinicizzato di Gastroenterologia, University of Verona, Italy. Gut 2000 Mar;46(3):420-6

Gene therapy for liver cirrhosis
Fujimoto J First Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan. J Gastroenterol Hepatol 2000 Mar;15 Suppl:D33-6

Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions
Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, Gazelle GS Department of Radiology, Ospedale Civile, Vimercate, Italy. Radiology 2000 Mar;214(3):761-8

Effects of prostaglandin E1 administration during hepatectomy for cirrhotic hepatocellular carcinoma
Hanazaki K, Kajikawa S, Fujimori Y, Nakata S, Shimozawa N, Koide N, Adachi W, Amano J Second Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan. Hepatogastroenterology 2000 Mar-Apr;47(32):461-4

Multiple macroregenerative nodules in liver cirrhosis due to Budd-Chiari syndrome. Case reports and review of the literature
Zhou H, Wolff M, Pauleit D, Fischer HP, Pfeifer U Department of Pathology, University of Bonn, Germany. Hepatogastroenterology 2000 Mar-Apr;47(32):522-7

Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis
Majno PE, Sarasin FP, Mentha G, Hadengue A Transplantation Unit, Department of Surgery, University Hospital, Geneva, Switzerland. Hepatology 2000 Apr;31(4):899-906

Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma
The Cancer of the Liver Italian Program (CLIP) Investigators. Hepatology 2000 Apr;31(4):840-5

Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up
Roncalli M, Bianchi P, Grimaldi GC, Ricci D, Laghi L, Maggioni M, Opocher E, Borzio M, Coggi G Departments of Pathology and Research Laboratories, Humanitas Clinical Institute of Rozzano, Milan, Italy. Hepatology 2000 Apr;31(4):846-50

Natural History of Hepatitis C: Its Impact on Clinical Management
Di BisceglieAdrian M. From the Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO. Hepatology, April 2000, p. 1014-1018, Vol. 31, No. 4

Better post-resectional survival in female cirrhotic patients with hepatocellular carcinoma
Lee CC, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hshia CY, Wu CW Department of Surgery, Veterans General Hospital-Taipei, Taiwan.Hepatogastroenterology 2000 Mar-Apr;47(32):446-9

Role of serum C-reactive protein as a marker of hepatocellular carcinoma in patients with cirrhosis
Lin ZY, Wang LY, Yu ML, Chen SC, Chuang WL, Hsieh MY, Tsai JF, Chang WY Department of Internal Medicine, Kaohsiung Medical University Hospital, Taiwan, Republic of China. J Gastroenterol Hepatol 2000 Apr;15(4):417-21

Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma
South Tohoku District Study Group. Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan. Am J Gastroenterol 2000 Apr;95(4):1036-40

Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis
Chapoutot C, Esslimani M, Joomaye Z, Ramos J, Perney P, Laurent C, Fabbro-Peray P, Larrey D, Domergue J, Blanc F Service de Medecine Interne E, Hopital St Eloi, Montpellier, France. Gut 2000 May;46(5):711-4

Effect of alcohol consumption on the progression of hepatitis c virus infection and risk of hepatocellular carcinoma in japanese patients
Khan KN, Yatsuhashi H Institute for Clinical Research, Nagasaki Chuo National Hospital, WHO Collaborating Center for Reference and Research on Viral Hepatitis, 2-1001-1 Kubara, Omura City, Nagasaki 856, Japan. Alcohol Alcohol 2000 May;35(3):286-295

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma
Khan MA, Combs CS, Brunt EM, Lowe VJ, Wolverson MK, Solomon H, Collins BT, Di Bisceglie AM Department of Internal Medicine, Saint Louis University School of Medicine, MO 63104, USA. J Hepatol 2000 May;32(5):792-7

Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma
Okusaka T, Okada S, Ueno H, Ikeda M, Yoshimori M, Shimada K, Yamamoto J, Kosuge T, Yamasaki S, Iwata R, Furukawa H, Moriyama N, Sakamoto M, Hirohashi S Department of Internal Medicine, National Cancer Center Hospital, Tokyo, Japan. Oncology 2000 May;58(4):293-9

Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy
Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, Fabregat J, Torras J Liver Transplant Unit, Ciutat Sanitaria Universitaria Bellvitge, University of Barcelona, Spain. J Am Coll Surg 2000 May;190(5):580-7

Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo
Raderer M, Hejna MH, Muller C, Kornek GV, Kurtaran A, Virgolini I, Fiebieger W, Hamilton G, Scheithauer W Department of Internal Medicine I, Division of Oncology, University of Vienna, A-1090 Vienna, Austria. Int J Oncol 2000 Jun;16(6):1197-201

The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C
Shintani Y, Yotsuyanagi H, Moriya K, Fujie H, Tsutsumi T, Takayama T, Makuuchi M, Kimura S, Koike K Department of Internal Medicine, University of Tokyo, Tokyo, Japan. Cancer 2000 Jun;88(11):2478-2486

Improved survival with screening for hepatocellular carcinoma
Wong LL, Limm WM, Severino R, Wong LM Department of Surgery, University of Hawaii School of Medicine and St Francis Medical Center, Honolulu, HI, USA. Liver Transpl 2000 May;6(3):320-5

Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide
Patt YZ, Hassan MM, Lozano RD, Ellis LM, Peterson JA, Waugh KA Department of Gastrointestinal Medical Oncology and Digestive Diseases, The University of Texas M. D. Anderson Cancer Center, Houston, USA. Am J Clin Oncol 2000 Jun;23(3):319-21

Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis
Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, Arase Y, Murashima N, Chayama K, Kumada H Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan. Cancer 2000 Jun;88(11):2471-2477

Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation
Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD Department of Medicine, Mount Sinai Medical Center, New York, New York, USA. Am J Gastroenterol 2000 Jun;95(6):1535-8

Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients
Giorgio A, Tarantino L, de Stefano G, Farella N, Catalano O, Cusati B, Del Viscovo L, Alaia A, Caturelli E Interventional Ultrasound Service-D, Cotugno Hospital Naples, Viale colli Aminei 491, 80131, Naples, Italy Eur J Ultrasound 2000 Jun 1;11(3):181-188

Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma
Chiappa A, Zbar AP, Audisio RA, Leone BE, Biella F, Staudacher C Department of General Surgery, European Institute of Oncology, Milan, Italy Eur J Surg Oncol 2000 Jun;26(4):387-392

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death
Degos F, Christidis C, Ganne-Carrie N, Farmachidi JP, Degott C, Guettier C, Trinchet JC, Beaugrand M, Chevret S Service d'Hepatogastro- enterologie, Hopital Beaujon, Clichy, France. Gut 2000;47:131-136 ( July )

Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization
Seong J, Park HC, Han KH, Lee DY, Lee JT, Chon CY, Moon YM, Suh CO Department of Radiation Oncology, Yonsei University Medical College, Seoul, South Korea Int J Radiat Oncol Biol Phys 2000 Jul 15;47(5):1331-1335

Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis
Ward J, Guthrie JA, Scott DJ, Atchley J, Wilson D, Davies MH, Wyatt JI, Robinson PJ Departments of Radiology, MRI Unit (J.W., J.A.G., D.J.S., J.A., P.J. R.), Medical Physics (D.W.), Hepatology (M.H.D.), andPathology (J.I. W.), St James's University Hospital, Leeds, United Kingdom. Radiology 2000 Jul;216(1):154-62

Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma
Chan ES, Chow PK, Tai B, Machin D, Soo K Meta-analysis Division, NMRC Clinical Trial & Epidemiology Research Unit, Singapore General Hospital, Ministry of Health Cochrane Database Syst Rev 2000;(2):CD001199




Chi siamo Faq Links Reviews News E-mail Casi clinici